The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis.
about
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in miceSynoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathyProtective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Rheumatoid arthritis as a hyper-endoplasmic-reticulum-associated degradation diseaseMechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.Physiopathology of spine metastasis.Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligandRisk of low bone mineral density in patients with rheumatoid arthritis treated with biologicsSerum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritisProgressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study.Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis.Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITYRole of denosumab in breast cancer.Coronary calcification and hormones.PGE₂ and BMP-2 in bone and cartilage metabolism: 2 intertwining pathways.Decrease of Markers Related to Bone Erosion in Serum of Patients with Musculoskeletal Disorders after Serial Low-Dose Radon Spa Therapy.The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis.Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
P2860
Q24536131-1CB350F2-C853-4F5D-BA95-E24E36046A0EQ24684755-FFEFBAFB-C862-4620-B596-F63A72E79FA5Q24812326-2A1F26A2-BB2D-4241-B0BE-B96EE563390BQ24812528-ED8A60AF-61FD-468C-BA9E-D5200C09C500Q34967810-5790EC37-47DE-4546-A930-1B528341C1C6Q35692236-79A529DC-8A52-43F8-A8DC-DB9A7662FA15Q35748007-726CEDE6-FA8C-4B99-9DF1-07593C755AB0Q35792875-FDD61C87-6156-464A-8ED8-424957825DB0Q36326701-D0C44876-B23C-4137-BFB0-619DA5C02C04Q36606767-6F25B26A-5EBF-41FE-AAAA-5B8CA7A8DCBDQ36911913-01D42D69-3FF2-4D07-9172-DE575F636D92Q37191397-829A7D98-533F-4E78-BC21-CAE9592E3FECQ37300823-1CC309A9-A210-49EF-9860-ED92D67398ADQ37307876-0C7E7731-0445-42C2-B6BA-A3F7C0BFEAE2Q37315782-E37F46A6-8DC4-4006-ADD9-67F54CE490E9Q37571986-53A5E8DA-32A1-4670-A246-D65B0D00570EQ37855315-DAA2285D-EDEB-46FB-B53B-3EF611DE6C9DQ38062546-429BB805-A52D-4B23-8528-9AB48BD73D8AQ41108607-14A22D41-D401-4000-BDF2-6BD62C225C2EQ46212623-0783C1A9-5C7D-47A0-8091-400BFD0E97CCQ53778903-478AA73D-52DD-4A57-ACB3-C26129AEE783Q54385952-F1E8B011-871A-4C94-B4D4-5738D97738D4
P2860
The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@ast
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@en
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@nl
type
label
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@ast
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@en
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@nl
prefLabel
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@ast
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@en
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@nl
P1476
The role of osteoprotegerin an ...... tment of rheumatoid arthritis.
@en
P2093
Heufelder AE
Hofbauer LC
P304
P356
10.1002/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S
P577
2001-02-01T00:00:00Z